[

serum institute of india

]

Latest from serum institute of india

Monkeypox: As India sees rise in cases, what Adar Poonawalla said about vaccine

  • India has so far reported eight cases of monkeypox, of which five have been from Kerala and three from Delhi. Of the five patients in Kerala, one succumbed to the disease on July 30, making it India's first monkeypox fatality.
Adar Poonawalla, chief executive officer of Serum Institute of India Ltd. (Bloomberg)
Adar Poonawalla, chief executive officer of Serum Institute of India Ltd. (Bloomberg)
Published on Aug 02, 2022 05:41 PM IST
Written by Sharangee Dutta | Edited by Aniruddha Dhar, New Delhi

Serum institute seeks government nod to export Covovax to the US

  • SII manufactures Covovax under a license from the vaccine’s developer, US-based Novavax. The export version of the vaccine is called Nuvaxovid and has been dispatched to New Zealand, Netherlands, Australia and Indonesia, where a total of at least 100 million doses have been sent.
SII chief executive officer Adar Poonawalla. (REUTERS)
SII chief executive officer Adar Poonawalla. (REUTERS)
Published on Jul 01, 2022 03:16 AM IST
By, New Delhi

Govt panel recommends market authorisation for Serum's cervical cancer vaccine

Cervical cancer in India ranks as the second most frequent cancer among women between 15 and 44 years of age.
The SII is also learnt to have made a presentation before the working group of HPV constituted separately by the NTAGI to review the data and usefulness of this vaccine last Wednesday.( representative image)
The SII is also learnt to have made a presentation before the working group of HPV constituted separately by the NTAGI to review the data and usefulness of this vaccine last Wednesday.( representative image)
Published on Jun 15, 2022 10:37 PM IST
PTI |

Covovax gets govt nod for 12-18 age group at private centres

On April 29, the National Technical Advisory Group on Immunisation (NTAGI)--the government’s technical panel--recommended inclusion of Covovax in the vaccination programme for children aged 12 and above.
Currently, while Covishield is available for all adults, Bharat Biotech’s Covaxin is available for those aged 15 and above. Corbevax is being used for children in the 12-15 age group (HT FILE)
Currently, while Covishield is available for all adults, Bharat Biotech’s Covaxin is available for those aged 15 and above. Corbevax is being used for children in the 12-15 age group (HT FILE)
Published on May 03, 2022 11:37 PM IST

'Covovax now available for children in India', says Adar Poonawalla, hails Modi

Serum Institute of India (SII) director for government and regulatory affairs Prakash Kumar Singh had written to the Centre recently requesting for Covovax's inclusion in the immunisation drive for children aged 12 to 17 years.
Adar Poonawalla’s Serum Institute of India locally manufactures the Oxford-AstraZeneca Covid vaccine under the brand name Covishield.(Reuters file)
Adar Poonawalla’s Serum Institute of India locally manufactures the Oxford-AstraZeneca Covid vaccine under the brand name Covishield.(Reuters file)
Updated on May 10, 2022 07:57 PM IST
By, New Delhi
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Saturday, August 13, 2022
Start 15 Days Free Trial Subscribe Now